What one share of ImmuCell holds
ImmuCell Corporation, founded in 1982 and a SEC-registered public company since 1987, is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves.
ImmuCell’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3.38 |
|---|---|
| Profit | $0.09 |
| Capex (buildings and equipment) | $0.18 |
| Free cash flow | $0.46 |
| Cash and investments | $0.98 |
| Debt | $0.91 |
| Book value | $3.45 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $1.52 | −$0.07 | $0.16 | −$0.19 | — | $3.25 |
| 2010 | $1.48 | −$0.13 | $0.04 | −$0.31 | — | $3.12 |
| 2011 | $1.71 | −$0.14 | $0.08 | −$0.09 | — | $3.00 |
| 2012 | $1.73 | $0.03 | $0.09 | $0.02 | — | $3.05 |
| 2013 | $1.95 | $0.04 | $0.19 | $0.16 | — | $3.10 |
| 2014 | $2.51 | −$0.06 | $0.51 | −$0.41 | — | $3.06 |
| 2015 | $3.23 | $0.38 | $0.86 | $0.06 | — | $3.47 |
| 2016 | $2.20 | $0.12 | $0.83 | −$0.88 | — | $4.07 |
| 2017 | $2.11 | −$0.03 | $3.59 | −$3.35 | — | $4.31 |
| 2018 | $2.00 | −$0.42 | $0.37 | −$0.44 | — | $3.90 |
| 2019 | $2.01 | −$0.19 | $0.20 | −$0.17 | — | $4.02 |
| 2020 | $2.13 | −$0.14 | $0.56 | −$0.38 | — | $3.92 |
| 2021 | $2.53 | −$0.01 | $0.34 | −$0.22 | — | $4.21 |
| 2022 | $2.40 | −$0.32 | $0.51 | −$0.71 | — | $3.92 |
| 2023 | $2.26 | −$0.75 | $0.24 | −$0.85 | — | $3.22 |
| 2024 | $3.24 | −$0.26 | $0.06 | −$0.01 | — | $3.06 |
| 2025 | $3.06 | −$0.12 | $0.14 | $0.14 | — | $2.99 |
Common questions about ImmuCell
How much does one share of ImmuCell earn?
Over the last 12 months, each share of ImmuCell earned $0.09 of profit on $3.38 of sales, keeping about 3¢ of every $1 (profit margin).
Does ImmuCell pay a dividend?
ImmuCell didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is ImmuCell’s book value per share?
ImmuCell’s book value is $3.45 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of ImmuCell have?
Each share of ImmuCell has $0.98 of cash and investments and $0.91 of debt, as of June 30, 2026.
What is ImmuCell’s free cash flow per share?
$0.46 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has ImmuCell bought back shares?
ImmuCell’s share count rose about 205% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.